Your browser doesn't support javascript.
loading
Transactivation of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs): Recent insights using luminescence and fluorescence technologies.
Kilpatrick, Laura E; Hill, Stephen J.
Affiliation
  • Kilpatrick LE; Division of Bimolecular Sciences and Medicinal Chemistry, Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK.
  • Hill SJ; Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, The Midlands, NG7 2UH, UK.
Curr Opin Endocr Metab Res ; 16: 102-112, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33748531
ABSTRACT
Alterations in signalling due to bidirectional transactivation of G protein-coupled receptor (GPCRs) and receptor tyrosine kinases (RTKs) are well established. Transactivation significantly diversifies signalling networks within a cell and has been implicated in promoting both advantageous and disadvantageous physiological and pathophysiological outcomes, making the GPCR/RTK interactions attractive new targets for drug discovery programmes. Transactivation has been observed for a plethora of receptor pairings in multiple cell types; however, the precise molecular mechanisms and signalling effectors involved can vary with receptor pairings and cell type. This short review will discuss the recent applications of proximity-based assays, such as resonance energy transfer and fluorescence-based imaging in investigating the dynamics of GPCR/RTK complex formation, subsequent effector protein recruitment and the cellular locations of complexes in living cells.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Curr Opin Endocr Metab Res Year: 2021 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Curr Opin Endocr Metab Res Year: 2021 Document type: Article Affiliation country: Reino Unido